Global SWFI for Reconstitution of Lyophilized Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global SWFI for Reconstitution of Lyophilized Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Sterile Water for Injection (SWFI) is sterile, nonpyrogenic, distilled water in a single dose container for intravenous administration after addition of a suitable solute. It may also be used as a dispensing container for diluent use.
SWFI are used for reconstitution of lyophilized drugs, diluent of injection solution and rinsing agent for endoscopy in various departments. SWFI for reconstitution of lyophilized drugs.
In this report, we only collect data of SWFI being sold as a part of set with LYO drug.
SWFI for Reconstitution of Lyophilized Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global SWFI for Reconstitution of Lyophilized Drugs market is projected to reach US$ 19 million in 2034, increasing from US$ 13 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2034. Demand from Vaccine and Biological Products are the major drivers for the industry.
Asia-Pacific and Europe are the two largest consumption regions, with a consumption market share nearly 40% and 30%. North America is also an important sales region.
Market competition is intense. Baxter, Hospira (ICU Medical), Vetter, Otsuka, ROVI, Fresenius Kabi, etc. are the leaders of the industry, they hold key technologies and patents, with high-end customers.
The classification of SWFI for reconstitution of lyophilized drugs includes Vials and Ampoules and Pre-Filled Syringes. The sales proportion of Vials and Ampoules is over 95%.
SWFI for reconstitution of lyophilized drugs is widely used for vaccines, Biological Products, Bio-pharmaceutical. The most proportion of SWFI for reconstitution of lyophilized drugs is used for vaccine, the proportion is about 73%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global SWFI for Reconstitution of Lyophilized Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Container, Application and Regions Listed in the Report
Baxter
Hospira (ICU Medical)
Vetter
Otsuka
ROVI
Fresenius Kabi
Shijiazhuang No. 4 Pharmaceutical
Hikma
Kelun
Deo Gratias Parenteral
Segment by Container
Vials and Ampoules
Pre-Filled Syringes
Vaccine
Biological Products
Bio-Pharmaceutical
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the SWFI for Reconstitution of Lyophilized Drugs market further
Chapter 1Product Definition, Product Containers, Volume and Revenue analysis of Each Container in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of SWFI for Reconstitution of Lyophilized Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the SWFI for Reconstitution of Lyophilized Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of SWFI for Reconstitution of Lyophilized Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, SWFI for Reconstitution of Lyophilized Drugs introduction, etc. SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of SWFI for Reconstitution of Lyophilized Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
SWFI are used for reconstitution of lyophilized drugs, diluent of injection solution and rinsing agent for endoscopy in various departments. SWFI for reconstitution of lyophilized drugs.
In this report, we only collect data of SWFI being sold as a part of set with LYO drug.
SWFI for Reconstitution of Lyophilized Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global SWFI for Reconstitution of Lyophilized Drugs market is projected to reach US$ 19 million in 2034, increasing from US$ 13 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2034. Demand from Vaccine and Biological Products are the major drivers for the industry.
Asia-Pacific and Europe are the two largest consumption regions, with a consumption market share nearly 40% and 30%. North America is also an important sales region.
Market competition is intense. Baxter, Hospira (ICU Medical), Vetter, Otsuka, ROVI, Fresenius Kabi, etc. are the leaders of the industry, they hold key technologies and patents, with high-end customers.
The classification of SWFI for reconstitution of lyophilized drugs includes Vials and Ampoules and Pre-Filled Syringes. The sales proportion of Vials and Ampoules is over 95%.
SWFI for reconstitution of lyophilized drugs is widely used for vaccines, Biological Products, Bio-pharmaceutical. The most proportion of SWFI for reconstitution of lyophilized drugs is used for vaccine, the proportion is about 73%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global SWFI for Reconstitution of Lyophilized Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Container, Application and Regions Listed in the Report
By Company
Baxter
Hospira (ICU Medical)
Vetter
Otsuka
ROVI
Fresenius Kabi
Shijiazhuang No. 4 Pharmaceutical
Hikma
Kelun
Deo Gratias Parenteral
Segment by Container
Vials and Ampoules
Pre-Filled Syringes
Segment by Application
Vaccine
Biological Products
Bio-Pharmaceutical
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the SWFI for Reconstitution of Lyophilized Drugs market further
Chapter 1Product Definition, Product Containers, Volume and Revenue analysis of Each Container in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of SWFI for Reconstitution of Lyophilized Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the SWFI for Reconstitution of Lyophilized Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of SWFI for Reconstitution of Lyophilized Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, SWFI for Reconstitution of Lyophilized Drugs introduction, etc. SWFI for Reconstitution of Lyophilized Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of SWFI for Reconstitution of Lyophilized Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices